Hussein A. Tawbi - Publications, H-index & Citations

Hussein A. Tawbi

University of Texas MD Anderson Cancer Center

61H指数

518论文数

2.4W被引数

收录论文 112

发表时间

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)黑色素瘤新辅助治疗的五年生存率：国际黑色素瘤新辅助治疗协作组（INMC）更新的汇总分析

Nature Medicine

IF50

2026-10-01

OAAI

Georgina V. Long; Inês Pires da Silva; Kristen A. Perry; Jurriaan Romano; Serigne N. Lo; Piyush Grover; Paolo A. Ascierto; Rodabe N. Amaria; Tina J. Hieken; Caroline Robert; Lucie Heinzerling; Shahneen Sandhu; Milton Barros; Tara C. Mitchell; Zeynep Eroglu; Igor V. Samoylenko; Lukas Flatz; Céleste Lebbé; Douglas B. Johnson; Piotr Rutkowski; Eva Muñoz-Couselo; Omid Hamid; Claudia Trojaniello; Domenico Mallardo; Matthew S. Block; Naima Hammoudi; Naima Benannoune; Dirk Tomsitz; Yang Wang; Cigdem Dinckal; Angelina Kuzmenko; Andrea Forschner; Matteo S. Carlino; Mathilde Jalving; Michael A. Postow; P. Francesco Ferrucci; Ellen Kapiteijn; Astrid A. M. van der Veldt; Karijn P. M. Suijkerbuijk; Laetitia da Meda; Hannah Burnette; Anna Czarnekca; Inderjit Mehmi; Geke Hospers; Sarah Lochrin; Alexander C. J. van Akkooi; Hussein A. Tawbi; Elizabeth M. Burton; Michael T. Tetzlaff; Bart A. van de Wiel; Robert V. Rawson; Christian U. Blank; Alexander M. Menzies

TPRG-07 PHASE II STUDY OF NIVOLUMAB (NIVO) IN COMBINATION WITH RELATLIMAB (RELA) IN PATIENTS WITH ACTIVE MELANOMA BRAIN METASTASES (MBM)TPRG-07 尼鲁单抗（NIVO）联合 relatlimab（RELA）治疗活动性黑色素瘤脑转移（MBM）患者的Ⅱ期研究

Neuro-Oncology Advances

IF4.1

2026-08-07

OAAI

Suzanne Phillips; Elizabeth Burton; Isabella Glitza Oliva; Rodabe Amaria; Jennifer McQuade; Michael K Wong; Sapna P Patel; Adi Diab; Caroline Chung; Denai Milton; Jared Malke; Julie Simon; Jeffrey Wefel; Jing Li; Michael Davies; Hussein Tawbi

PACM-04 ONCOLYTIC ADENOVIRUS RGDOX INDUCES SYSTEMIC CD8+ T CELL–MEDIATED IMMUNITY ACROSS INTRACRANIAL MELANOMA METASTASES: RATIONALE FOR A PHASE I TRIAL PACM-04 溶瘤腺病毒RGDOX在颅内黑色素瘤转移中诱导系统性CD8+ T细胞介导的免疫反应：I期临床试验的依据

Neuro-Oncology Advances

IF4.1

2026-08-07

OAAI

Yi Du; Sanjay Singh; Alejandra Duran; Xizi Wu; Chibawanye Ene; Joy Gumin; Hong Jiang; Dong Ho Shin; Xuejun Fan; David Peng; Javier Gomez; Manu Sebastian; Naema Nayyar; Priscilla Brastianos; Hussein Tawbi; Michael Davies; Frederick Lang; Candelaria Gomez-Manzano; Juan Fueyo-Margareto; Christopher Alvarez-Breckenridge

Optimizing pathological response assessment after neoadjuvant immunotherapy: linking clinical practice to drug development 优化新辅助免疫治疗后的病理反应评估: 将临床实践与药物开发联系起来

Annals of Oncology

IF65.4

2026-01-19

PREAI

H. Tawbi; D. Massi

The evolving landscape of brain metastasis: volume II 脑转移的演变景观: 第二卷

Trends in Cancer

IF17.5

2025-12-02

OAAI

Manuel Valiente; Carey Anders; Adrienne Boire; Benjamin Izar; Nuria Kotecki; Srinivas Malladi; Joan Massagué; Nelson S. Moss; Josh Neman; Matthias Preusser; Sanne Schagen; Peter M. Siegel; Hussein Tawbi; Varun Venkataramani; Frank Winkler; Gelareh Zadeh; Johanna A. Joyce

Soluble immune factor profiles in blood and CSF associated with LRRK2 mutations and Parkinson’s disease 与LRRK2突变和帕金森病相关的血液和脑脊液中的可溶性免疫因子谱

npj Parkinson's Disease

IF8.2

2025-11-27

OAAI

Roshni Jaffery; Yuhang Zhao; Sarfraz Ahmed; Jackson G. Schumacher; Jae Ahn; Leilei Shi; Yujia Wang; Yukun Tan; Jiayin Zhang; Ken Chen; Hussein Tawbi; Jian Wang; Michael A. Schwarzschild; Weiyi Peng; Xiqun Chen

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial 辅助性尼沃鲁单抗和雷拉利单抗在III/IV期黑色素瘤中的应用：随机III期RELATIVITY-098试验

Nature Medicine

IF50

2025-10-18

OAAI

Georgina V. Long; Charlie Garnett-Benson; Sonia Dolfi; Paolo A. Ascierto; Jun Guo; Ahmad A. Tarhini; Sunandana Chandra; Eva Muñoz-Couselo; Michele Del Vecchio; Andreia Cristina de Melo; Margaret Callahan; Helen Gogas; Reinhard Dummer; Dirk Schadendorf; Peter Koelblinger; Gaelle Quereux; Ioannis Thomas; Jia Xin Yu; Andrew Fisher; Bonnie Wang; Patrick Djidel; Armand Chouzy; Mark Semaan; Bohang Chen; Alicia M. Y. Cheong; Hussein A. Tawbi

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma 淋巴细胞清除、肿瘤浸润淋巴细胞，以及高剂量与低剂量IL-2后给予pembrolizumab在转移性黑色素瘤患者中的应用

OncoImmunology

IF6.3

2025-08-15

OAAI

Merve Hasanov; Simin Kiany; Marie-Andrée Forget; Roland Bassett; Michael A. Davies; Adi Diab; Jeffrey E. Gershenwald; Isabella C. Glitza; Jeffrey E. Lee; Anthony Lucci; Jennifer L. McQuade; Sapna P. Patel; Merrick I. Ross; Hussein A. Tawbi; Jennifer A. Wargo; Michael K. Wong; Chantale Bernatchez; Patrick Hwu; Cara Haymaker; Rodabe N. Amaria

A plain language summary of POLARIS: a study to look at different doses of encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasis POLARIS研究的简明语言摘要：一项针对BRAF V600突变黑色素瘤脑转移患者，评估encorafenib联合binimetinib不同剂量的研究

FUTURE ONCOLOGY

IF2.6

2025-05-26

OAAI

Menzies, Alexander M.; Long, Georgina V.; Kohn, Amiee; Tawbi, Hussein; Webe, Jeffrey; Flaherty, Keith; McArthur, Grant A.; Ascierto, Paolo A.; Pfluger, Yanina; Lewis, Karl; Tsai, Katy K.; Hamid, Omid; Prenen, Hans; Fein, Luis; Wang, Erjian; Guenzel, Carolin; Zhang, Fan; Kleh, Joseph F.; di Pietro, Alessandra; Davies, Michael A.

FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma Fdg-pet与黑色素瘤新辅助免疫治疗的病理反应和生存率的关系

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2025-03-25

OAAI

Zhou, Li; Barros e Silva, Milton Jose; Hsiao, Edward; Eroglu, Zeynep; Sandhu, Shahneen; Samoylenko, Igor; Lo, Serigne N.; Carlino, Matteo S.; Au-Yeung, George; Gonzalez, Maria; Spillane, Andrew J.; Pennington, Thomas E.; Shannon, Kerwin F.; Kapoor, Rony; Burton, Elizabeth M.; Tawbi, Hussein A.; Amaria, Rodabe N.; Blank, Christian U.; Duprat, Joao Pedreira; de Paula, Rafaela Brito; Gyorki, David E.; Saw, Robyn P. M.; Ch'Ng, Sydney; Rawson, Robert, V; Scolyer, Richard A.; da Silva, Ines Pires; van Akkooi, Alexander C. J.; Long, Georgina, V; Menzies, Alexander M.

Nivolumab plus relatlimab vs nivolumab in previously untreated metastatic or unresectable melanoma: 3-year subgroup analyses from RELATIVITY-047 Nivolumab联合relatlimab与nivolumab单药治疗既往未治疗的转移性或不可切除性黑色素瘤：RELATIVITY-047研究的3年亚组分析

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Schadendorf, D.; Tawbi, H. A.; Hodi, F. S.; Lipson, E. J.; Ascierto, P. A.; Medina Soto, F. A.; Maio, M.; Hernberg, M.; Mackiewicz, J.; Prey, S.; Mujika Eizmendi, M. K.; Atkinson, V. G.; Hassel, J. C.; Cinat, G.; Keidel, S.; Rodriguez, S.; Wang, P. T.; Dolfi, S.; Long, G. V.

Symptomatic melanoma brain metastases: A call for clear definitions and adoption of standardized tools 有症状的黑色素瘤脑转移: 呼吁明确定义和采用标准化工具

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-09-01

OAAI

Le Rhun, Emilie; Weller, Michael; Anders, Carey; Larkin, James; Li, Jing; Moss, Nelson S.; Tawbi, Hussein; Dummer, Reinhard

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy (vol 13, 1970, 2022)

NATURE COMMUNICATIONS

IF15.7

2024-07-04

OAAI

Kim, Sang T.; Chu, Yanshuo; Misoi, Mercy; Suarez-Almazor, Maria E.; Tayar, Jean H.; Lu, Huifang; Buni, Maryam; Kramer, Jordan; Rodriguez, Emma; Hussain, Zulekha; Neelapu, Sattva S.; Wang, Jennifer; Shah, Amishi Y.; Tannir, Nizar M.; Campbell, Matthew T.; Gibbons, Don L.; Cascone, Tina; Lu, Charles; Blumenschein, George R.; Altan, Mehmet; Lim, Bora; Valero, Vincente; Loghin, Monica E.; Tu, Janet; Westin, Shannon N.; Naing, Aung; Garcia-Manero, Guillermo; Abdel-Wahab, Noha; Tawbi, Hussein A.; Hwu, Patrick; Oliva, Isabella C. Glitza; Davies, Michael A.; Patel, Sapna P.; Zou, Jun; Futreal, Andrew; Diab, Adi; Wang, Linghua; Nurieva, Roza

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results (vol 9, pg 898, 2023)

NATURE MEDICINE

IF50

2024-04-22

OAAI

Glitza Oliva, Isabella C.; Ferguson, Sherise D.; Bassett, Roland; Foster, Alexandra P.; John, Ida; Hennegan, Tarin D.; Rohlfs, Michelle; Richard, Jessie; Iqbal, Masood; Dett, Tina; Lacey, Carol; Jackson, Natalie; Rodgers, Theresa; Phillips, Suzanne; Duncan, Sheila; Haydu, Lauren; Lin, Ruitao; Amaria, Rodabe N.; Wong, Michael K.; Diab, Adi; Yee, Cassian; Patel, Sapna P.; Mcquade, Jennifer L.; Fischer, Grant M.; Mccutcheon, Ian E.; O'Brien, Barbara J.; Tummala, Sudhakar; Debnam, Matthew; Guha-Thakurta, Nandita; Wargo, Jennifer A.; Carapeto, Fernando C. L.; Hudgens, Courtney W.; Huse, Jason T.; Tetzlaff, Michael T.; Burton, Elizabeth M.; Tawbi, Hussein A.; Davies, Michael A.

Results from monotherapy dose escalation of MDNA11, a long-acting IL-2 superkine, in a phase 1/2 trial show evidence of single-agent activity in advanced solid tumors

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Atkinson, Victoria G.; Antras, Jesus F.; Bedard, Philippe; Brenner, Warren; Brown, Jacqueline; Lemech, Charlotte R.; Lloyd, Peter; Margolin, Kim; Mathew, Matthen; Park, John J.; Thomas, Sajeve; Twardowski, Przemyslaw; Gardner, Humphrey; Prawira, Amy; Coello, Melissa; Ebrahimimizadeh, Walead; To, Minh D.; Merchant, Rosemina; Karanam, Sudhir Madduri; Yavari, Arash; Siu, Lillian L.; Tawbi, Hussein A.; Ascierto, Paolo A.

Randomized placebo-controlled, biomarker-stratified phase 1b microbiome modulation trial for metastatic melanoma demonstrates impact of antibiotic pre-conditioning regimen on the microbiome and immunity

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Oliva, Isabella C. Glitza; Seo, Yongwoo David; Spencer, Christine N.; Wortman, Jennifer R.; Burton, Elizabeth M.; Alayli, Farah A.; Loo, Christopher; Gautam, Shikha; Damania, Ashish V.; Densmore, Julie; Fairchild, Justin; Cabanski, Christopher; Wong, Matthew C.; Peterson, Christine B.; Weiner, Brian; Hicks, Nathan; Aunins, John; McChalicher, Christopher; Tetzlaff, Michael T.; Hamid, Omid; Ott, Patrick A.; Boland, Genevieve M.; Sullivan, Ryan J.; Grossmann, Kenneth F.; Ajami, Nadim J.; LaVallee, Theresa M.; Henn, Matthew R.; Tawbi, Hussein A.; Wargo, Jennifer A.

Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity 黑色素瘤中随机安慰剂对照、生物标志物分层Ib期微生物组调节: 抗生素预处理对微生物组和免疫的影响

CANCER DISCOVERY

IF33.3

2024-04-03

OAAI

Glitza, Isabella C.; Seo, Yongwoo David; Spencer, Christine N.; Wortman, Jennifer R.; Burton, Elizabeth M.; Alayli, Farah A.; Loo, Christopher P.; Gautam, Shikha; Damania, Ashish; Densmore, Julie; Fairchild, Justin; Cabanski, Christopher R.; Wong, Matthew C.; Peterson, Christine B.; Weiner, Brian; Hicks, Nathan; Aunins, John; McChalicher, Christopher; Walsh, Emily; Tetzlaff, Michael T.; Hamid, Omid; Ott, Patrick A.; Boland, Genevieve M.; Sullivan, Ryan J.; Grossmann, Kenneth F.; Ajami, Nadim J.; LaVallee, Theresa; Henn, Matthew R.; Tawbi, Hussein A.; Wargo, Jennifer A.

POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis POLARIS: 一项2期试验，评估BRAF V600-mutant黑色素瘤脑转移患者的高剂量和标准剂量方案

NEURO-ONCOLOGY ADVANCES

IF4.1

2024-03-18

OAAI

Menzies, Alexander M.; Long, Georgina, V; Kohn, Amiee; Tawbi, Hussein; Weber, Jeffrey; Flaherty, Keith; McArthur, Grant A.; Ascierto, Paolo A.; Pfluger, Yanina; Lewis, Karl; Tsai, Katy K.; Hamid, Omid; Prenen, Hans; Fein, Luis; Wang, Erjian; Guenzel, Carolin; Zhang, Fan; Kleha, Joseph F.; di Pietro, Alessandra; Davies, Michael A.

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

NATURE CANCER

IF28.5

2024-02-13

PREAI

Roland, Christina L.; Nassif Haddad, Elise F.; Keung, Emily Z.; Wang, Wei-Lien; Lazar, Alexander J.; Lin, Heather; Chelvanambi, Manoj; Parra, Edwin R.; Wani, Khalida; Guadagnolo, B. Ashleigh; Bishop, Andrew J.; Burton, Elizabeth M.; Hunt, Kelly K.; Torres, Keila E.; Feig, Barry W.; Scally, Christopher P.; Lewis, Valerae O.; Bird, Justin E.; Ratan, Ravin; Araujo, Dejka; Zarzour, M. Alexandra; Patel, Shreyaskumar; Benjamin, Robert; Conley, Anthony P.; Livingston, J. Andrew; Ravi, Vinod; Tawbi, Hussein A.; Lin, Patrick P.; Moon, Bryan S.; Satcher, Robert L.; Mujtaba, Bilal; Witt, Russell G.; Traweek, Raymond S.; Cope, Brandon; Lazcano, Rossana; Wu, Chia-Chin; Zhou, Xiao; Mohammad, Mohammad M.; Chu, Randy A.; Zhang, Jianhua; Damania, Ashish; Sahasrabhojane, Pranoti; Tate, Taylor; Callahan, Kate; Nguyen, Sa; Ingram, Davis; Morey, Rohini; Crosby, Shadarra; Mathew, Grace; Duncan, Sheila; Lima, Cibelle F.; Blay, Jean-Yves; Fridman, Wolf Herman; Shaw, Kenna; Wistuba, Ignacio; Futreal, Andrew; Ajami, Nadim; Wargo, Jennifer A.; Somaiah, Neeta

Safety and efficacy of low dose (LD) ipilimumab (Ipi) plus pembrolizumab (pem) in checkpoint inhibitor (CPI) naive patients (pts) with melanoma brain metastases (MBM)

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

PREAI

Glitza, I. C.; Milton, D.; Honaker, V.; Turner, S.; Hennegan, T.; Beckham, T.; Amaria, R.; Patel, S.; Diab, A.; Wong, M.; Mcquade, J.; Yee, C.; Davies, M.; Burton, E.; Tawbi, H. A.

研究方向